Fredun Pharmaceuticals Ltd.
Snapshot View

1013.45 +21.35 ▲2.2%

08 February 2023, 10:09:00 AM
Volume: 172

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fredungroup.com
Market Cap 449.65 Cr.
Enterprise Value(EV) 534.71 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.73 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 45.66 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 188.86 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.25 Calculated using Price: 992.10
Dividend Yield 0.07 Period Ending 2022-03
No. of Shares Subscribed 0.45 Cr. 4,532,272 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing of pharmaceutical products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.15%
1 Week
+1.29%
1 Month
-6.96%
3 Month
-25.02%
6 Month
+7.94%
1 Year
-0.20%
2 Year
+101.90%
5 Year
+610.20%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.79 9.68 33.46 33.88 13.02 14.59 4.74 4.77 11.42
Return on Capital Employed (%) 14.50 14.23 24.67 18.16 15.90 20.56 10.36 9.53 14.60
Return on Assets (%) 1.50 1.26 3.23 2.88 2.59 4.84 1.54 1.33 3.63

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3 3 4 7 22 39 41 43 68 74
Non Curr. Liab. 3 4 7 8 4 13 14 32 45 3
Curr. Liab. 12 16 32 40 53 53 86 86 74 155
Minority Int.
Equity & Liab. 18 23 43 56 79 105 141 162 187 233
Non Curr. Assets 8 10 15 21 28 32 32 32 34 37
Curr. Assets 10 13 28 35 51 73 109 130 153 196
Misc. Exp. not W/O 0
Total Assets 18 23 43 56 79 105 141 162 187 233

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 21 25 42 57 60 97 113 134 224 269
Other Income 0 0 1 2 0 1 1 1 2
Total Income 22 26 43 59 60 98 113 135 226 269
Total Expenditure -20 -24 -38 -53 -54 -87 -104 -125 -209 -245
PBIDT 2 2 5 5 6 11 9 11 17 23
Interest -1 -1 -2 -2 -2 -3 -4 -4 -6 -7
Depreciation -1 -1 -1 -1 -1 -1 -2 -2 -2 -3
Taxation 0 0 -1 -1 -1 -2 -1 -1 -2 -3
Exceptional Items 0 0 -1
PAT 0 0 1 1 2 4 2 2 6 10
Adjusted EPS 1 1 4 5 4 11 5 5 14 22

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 -1 2 3 4 17 1 -11 0 -2
Cash Fr. Inv. -1 -2 -3 -6 -7 -8 -5 -1 -1 -4
Cash Fr. Finan. 0 2 1 3 3 -8 4 14 -1 7
Net Change 0 0 0 1 -1 1 0 2 -2 1
Cash & Cash Eqvt 1 0 1 1 1 1 1 3 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 52.04 52.04 52.04 52.04 51.27 51.27 51.04 51.04 50.34
Public 47.96 47.96 47.96 47.96 48.73 48.73 48.96 48.96 49.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 5.54 5.54 5.54 5.54 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 28 Jan 2023
Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 27Th January 2023
Revised outcome of the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company) at their Meeting held on Friday 27th January 2023 had considered and approved the following item:

1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 31st December 2022 along with the Limited Review Report as issued by M/s. Savla & Associates Statutory Auditors of the Company; copies of which are attached hereunder;

The Meeting of the Board Commenced at 2.00 P.M. and concluded at 08:00 P.M.
Sat, 28 Jan 2023
Revised Financial Results For Quarter Ended December 31 2022
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company) at their Meeting held on Friday 27th January 2023 had considered and approved the following item:

1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 31st December 2022 along with the Limited Review Report as issued by M/s. Savla & Associates Statutory Auditors of the Company; copies of which are attached hereunder;

The Meeting of the Board Commenced at 2.00 P.M. and concluded at 08:00 P.M.
Fri, 27 Jan 2023
Board Meeting Outcome for Outcome Of Board Meeting
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company) at their Meeting held on Friday 27th January 2023 had considered and approved the following item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 31st December 2022 along with the Limited Review Report as issued by M/s. Savla & Associates Statutory Auditors of the Company; copies of which are attached hereunder;The Meeting of the Board Commenced at 2.00 P.M. and concluded at 08:00 P.M.

Technical Scans View Details >>

Tue, 07 Feb 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,002.40 -0.4%
Cipla Ltd. 83,244.79 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,475.55 +0.8%
Divi's Laboratories Ltd. 72,982.62 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. 51,953.07 1,538.55 +0.2%
Zydus Lifesciences Ltd. 48,525.07 476.75 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-12 31.56 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 476.75 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-12 3.67 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 476.75 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 476.75 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.75 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.75 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 476.75 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,002.40 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,475.55 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,805.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,341.90 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.55 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 476.75 -0.6%

FAQ's On Fredun Pharmaceuticals Ltd.

What is Fredun Pharma share price?

Can I buy Fredun Pharma shares now?

What is the Dividend Yield of Fredun Pharma?

What is the Market Cap of Fredun Pharma?

What are the key metrics to analyse Fredun Pharma?

What is the 52 Week High and Low of Fredun Pharma?

What is the trend of Fredun Pharma share price?